SEC Form 4 · accession 0001645627-18-000048
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 17, 2018
Accepted (ET)
Aug 22, 2018 · 2:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 17, 2018 | P | 2,000 | $0.0236 | A | 25,636,198 | D | |
| Common Stock | Aug 17, 2018 | P | 2,000 | $0.0236 | A | 25,638,198 | D | |
| Common Stock | Aug 17, 2018 | P | 1,000 | $0.0236 | A | 25,639,198 | D | |
| Common Stock | Aug 17, 2018 | P | 2,000 | $0.027 | A | 25,641,198 | D | |
| Common Stock | Aug 17, 2018 | P | 2,000 | $0.027 | A | 25,643,198 | D | |
| Common Stock | Aug 17, 2018 | P | 2,000 | $0.026 | A | 25,645,198 | D | |
| Common Stock | Aug 20, 2018 | P | 2,000 | $0.027 | A | 25,647,198 | D | |
| Common Stock | Aug 20, 2018 | P | 3,000 | $0.0246 | A | 25,650,198 | D | |
| Common Stock | Aug 20, 2018 | P | 3,000 | $0.0248 | A | 25,653,198 | D | |
| Common Stock | Aug 21, 2018 | P | 1,000 | $0.0261 | A | 25,654,198 | D | |
| Common Stock | Aug 21, 2018 | P | 2,000 | $0.025 | A | 25,656,198 | D | |
| Common Stock | Aug 21, 2018 | P | 3,000 | $0.0246 | A | 25,659,198 | D |
Table II — derivative securities
No Table II lines on this filing.